Tead2-KO Mouse
Common Name
Tead2-KO
제품 ID
S-KO-05205
Backgroud
C57BL/6NCya
품종 계통계통 ID
KOCMP-21677-Tead2-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Tead2-KO Mouse (카탈로그 번호 S-KO-05205)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Tead2-KO
품종 계통계통 ID
KOCMP-21677-Tead2-B6N-VA
유전자명
제품 ID
S-KO-05205
유전자 별칭
ETF, Etdf, TEF4, TEF-4, ETEF-1, TEAD-2
배경
C57BL/6NCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 7
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000033060
NCBI 전사체 ID
NM_011565
타겟 영역
Exon 3~6
유효 영역 크기
~2.6 kb
유전자 연구 개요
TEAD2, a member of the TEA domain transcription factor family, is involved in crucial biological processes. It participates in the Hippo signaling pathway, which is vital for tissue growth, organ size control, and cell fate determination [1,4,5,7,9]. TEAD2 also plays a role in maintaining ground-state pluripotency in mouse embryonic stem cells, facilitating the transition between different culture conditions by mediating chromatin looping and enhancer-promoter interactions [2].
In disease-related studies, TEAD2 has been implicated in multiple cancers. In hepatocellular carcinoma (HCC), deletion of TAZ, which acts with TEAD2, consistently decreased HCC growth and mortality, while overexpression of activated TAZ triggered HCC. TAZ-and MET/CTNNB1-S45Y-driven HCC required the expression of TEAD2, and TEAD2 had a profound effect on patient survival [1]. Additionally, TEAD2 promoted HCC development and sorafenib resistance by transcriptionally activating TAK1 [4]. In pancreatic ductal adenocarcinoma, a TEAD2-driven endothelial-like program was associated with basal-like differentiation and metastasis, and genetic and pharmacologic inhibitions of TEAD2 impaired cancer progression [3]. In melanoma, vemurafenib resistance upregulated STIM1 through an EGF/EGFR-YAP1/TEAD2 signaling axis [6]. In colorectal cancer, PHF5A promoted cancer progression by alternative splicing of TEAD2 to activate YAP signaling [8].
In conclusion, TEAD2 is essential for maintaining pluripotency and plays significant roles in cancer development and progression, especially in HCC, pancreatic cancer, melanoma, and colorectal cancer. The use of gene knockout or conditional knockout mouse models in these studies has been crucial in revealing the function of TEAD2 in these biological processes and disease conditions, providing potential therapeutic targets for these cancers.
References:
1. Saito, Yoshinobu, Yin, Dingzi, Kubota, Naoto, Wangensteen, Kirk J, Schwabe, Robert F. 2023. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. In Gastroenterology, 164, 1279-1292. doi:10.1053/j.gastro.2023.02.043. https://pubmed.ncbi.nlm.nih.gov/36894036/
2. Guo, Rong, Dong, Xiaotao, Chen, Feng, Hu, Gongcheng, Yao, Hongjie. 2024. TEAD2 initiates ground-state pluripotency by mediating chromatin looping. In The EMBO journal, 43, 1965-1989. doi:10.1038/s44318-024-00086-5. https://pubmed.ncbi.nlm.nih.gov/38605224/
3. Yoo, Hye-Been, Moon, Jin Woo, Kim, Hwa-Ryeon, Kim, Mi-Young, Roe, Jae-Seok. 2023. A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. In Gastroenterology, 165, 133-148.e17. doi:10.1053/j.gastro.2023.02.049. https://pubmed.ncbi.nlm.nih.gov/36907523/
4. Zhang, Yahui, Ren, Yidan, Dong, Guoying, Wang, Yunshan, Zhao, Wei. . TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation. In Molecular cancer research : MCR, 22, 1102-1116. doi:10.1158/1541-7786.MCR-24-0060. https://pubmed.ncbi.nlm.nih.gov/39106149/
5. Joo, Jong Seok, Cho, Sang Yeon, Rou, Woo Sun, Eun, Hyuk Soo, Lee, Byung Seok. 2020. TEAD2 as a novel prognostic factor for hepatocellular carcinoma. In Oncology reports, 43, 1785-1796. doi:10.3892/or.2020.7578. https://pubmed.ncbi.nlm.nih.gov/32323824/
6. Bai, Weiyu, Yan, Chenghao, Yang, Yichen, Sun, Yan, Sun, Jianwei. 2024. EGF/EGFR-YAP1/TEAD2 signaling upregulates STIM1 in vemurafenib resistant melanoma cells. In The FEBS journal, 291, 4969-4983. doi:10.1111/febs.17272. https://pubmed.ncbi.nlm.nih.gov/39298503/
7. Park, Sujin, Mossmann, Dirk, Chen, Qian, Heim, Markus H, Hall, Michael N. . Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis. In Molecular cell, 82, 4246-4261.e11. doi:10.1016/j.molcel.2022.10.027. https://pubmed.ncbi.nlm.nih.gov/36400009/
8. Chang, Yue, Zhao, Yulu, Wang, Liya, Chu, Xiaoyuan, Chen, Cheng. 2021. PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2. In Molecular therapy. Nucleic acids, 26, 1215-1227. doi:10.1016/j.omtn.2021.10.025. https://pubmed.ncbi.nlm.nih.gov/34853721/
9. Alder, Olivia, Cullum, Rebecca, Lee, Sam, Marra, Marco A, Hoodless, Pamela A. 2014. Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. In Cell reports, 9, 261-271. doi:10.1016/j.celrep.2014.08.046. https://pubmed.ncbi.nlm.nih.gov/25263553/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.